Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan

Patients with type 2 diabetes mellitus (T2DM) are at increased risk of non-alcoholic fatty liver disease (NAFLD) and might eventually progress to advanced fibrosis, cirrhosis and hepatocellular carcinoma (HCC). Recommendations on whether to screen for NAFLD in diabetic patients remains conflicted be...

Full description

Bibliographic Details
Main Authors: Tran Thi Khanh Tuong, Dang Khoa Tran, Pham Quang Thien Phu, Tong Nguyen Diem Hong, Thien Chu Dinh, Dinh Toi Chu
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Diagnostics
Subjects:
nafld
nash
diabetes
fibrosis
steatosis
fibroscan
cap
Online Access:https://www.mdpi.com/2075-4418/10/3/159

Internet

https://www.mdpi.com/2075-4418/10/3/159

Similar Items